Peer-influenced content. Sources you trust. No registration required. This is HCN.
Optometry and Vision Science (OVS)
Discover the most recent developments in retinal imaging and visual function research, as well as how they have revolutionized patient care and our understanding of disease causes. Explore this thorough overview to discover more about how these developments are revealing previously undetected pathological alterations and resulting in major improvements in the treatment of conditions like age-related macular degeneration, macular edema, and diabetic retinopathy.
Optometry July 24th 2023
Psych Congress Network
Explore the recent identification of two distinct neurophysiological subtypes of major depressive disorder, a key advancement that could refine your approach to personalized treatments in mental health.
Psychiatry July 19th 2023
Multiple Sclerosis News Today
Gadoquatrane, a promising GBCA, enters Phase 3 clinical testing, potentially offering safer MRI procedures and advancing diagnostic capabilities for patients with CNS disorders, including MS.
Neurology July 11th 2023
HIT Consultant
Artificial intelligence, especially computer vision, could revolutionize gastroenterology by improving diagnostic accuracy, streamlining care, and paving the way for scientific advancements in disease analysis and therapy sequencing.
Gastroenterology July 6th 2023
MashupMD
Enhancing Cardiovascular Disease Risk Prediction: Comparing Coronary Artery Calcium and Polygenic Risk Scores A Northwestern University study revealed that both coronary artery calcium and polygenic risk scores significantly influence 10-year risk prediction for coronary heart disease. However, coronary artery calcium score demonstrated superior predictive power, reinforcing the integration of these novel tools in risk prediction models. “What this study says is that in white participants enrolled in 2 observational studies, identifying coronary calcium predicted future cardiac events better than our currently available polygenic risk scores.” Dr. Karol E. Watson, PhD, professor of medicine and cardiology at the David Geffen School of Medicine at the University of California Los Angeles
Cardiology June 6th 2023
Journal of Neurology, Neurosurgery & Psychiatry
Dopaminergic Dysfunction: A Key Player in Parkinson’s Disease Motivational Symptoms This study reveals a significant link between dopaminergic dysfunction and the emergence of motivational symptoms in Parkinson’s disease. Striatal DAT imaging emerges as a potential tool for predicting apathy/anhedonia risk, opening new avenues for intervention strategies.
Neurology June 6th 2023